fda bpc-157 status not approved warning Exciting news for peptides coming out of today's committee hearing! The Pharmacy Compounding Advisory Committee voted 8-6 to recommend adding BPC- 157 to the 503A Bulks List for use in compounding for An FDA advisory committee voted
An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with FDA Advisory Panel Votes to Loosen Rules on BPC 157, TB 500, and MOTS C Despite Agency Scientists' Opposition BPC 157 Legal Status: FDA Regulations and Compounding FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT
Pay in 4 interest-free payments of $6.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


